FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068127030> ?p ?o ?g. }

• W2068127030 endingPage "42" @default.
• W2068127030 startingPage "35" @default.
• W2068127030 abstract "Purpose: To evaluate the efficacy and safety of levetiracetam (LEV) in refractory crypto/symptomatic, partial or generalised epilepsy in children, adolescents and young adults. Methods: We performed a prospective open label add-on study in 99 patients (age 12 months to 32 years, mean 14 years) with partial or generalised, crypto/symtpomatic seizures. Levetiracetam was added to no more than two baseline AEDs and the efficacy was rated according to seizure type and frequency. Results: LEV was initiated at the starting dose of 10 mg/kg/day with 5-day increments up to 50 mg/kg/day, unless it was not tolerated. Concomitant therapy was generally not modified throughout the study. After a mean follow-up period of 6.7 months (range 3 weeks to 29 months), 11 patients (11.1%) were free of seizures (cryptogenic partial epilepsy, 5; symptomatic partial epilepsy, 6). A more than 75% seizure decrease was found in 14 patients (14.1%) and >50% in 8 (8.1%). Seizures were unchanged in 38 (38.4%), and worsened in 23 (23.2%). Mild and transient adverse side effects were found in 17 patients (17.2%), mostly represented by irritability and drowsiness. Conclusion: LEV appears to be well tolerated in children and adolescents with severe epilepsy and seems to be a broad spectrum AED, though in our experience, it was more effective against partial seizures with or without secondarily generalisation. LEV efficacy in other epilepsy syndrome should be evaluated further in homogeneous, more selected patients." @default.
• W2068127030 created "2016-06-24" @default.
• W2068127030 creator A5007451076 @default.
• W2068127030 creator A5015105864 @default.
• W2068127030 creator A5017782497 @default.
• W2068127030 creator A5018746510 @default.
• W2068127030 creator A5052479060 @default.
• W2068127030 creator A5056709060 @default.
• W2068127030 creator A5063922177 @default.
• W2068127030 creator A5073113713 @default.
• W2068127030 creator A5074118804 @default.
• W2068127030 creator A5077685439 @default.
• W2068127030 creator A5080828723 @default.
• W2068127030 date "2004-03-01" @default.
• W2068127030 modified "2023-10-13" @default.
• W2068127030 title "Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy" @default.
• W2068127030 cites W1979558709 @default.
• W2068127030 cites W1993464501 @default.
• W2068127030 cites W2025490080 @default.
• W2068127030 cites W2027922130 @default.
• W2068127030 cites W2069166395 @default.
• W2068127030 cites W2093714074 @default.
• W2068127030 cites W2111375681 @default.
• W2068127030 cites W2135373623 @default.
• W2068127030 cites W4236676256 @default.
• W2068127030 doi "https://doi.org/10.1016/j.eplepsyres.2004.03.006" @default.
• W2068127030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15135165" @default.
• W2068127030 hasPublicationYear "2004" @default.
• W2068127030 type Work @default.
• W2068127030 sameAs 2068127030 @default.
• W2068127030 citedByCount "44" @default.
• W2068127030 countsByYear W20681270302012 @default.
• W2068127030 countsByYear W20681270302013 @default.
• W2068127030 countsByYear W20681270302014 @default.
• W2068127030 countsByYear W20681270302015 @default.
• W2068127030 countsByYear W20681270302016 @default.
• W2068127030 countsByYear W20681270302017 @default.
• W2068127030 countsByYear W20681270302020 @default.
• W2068127030 countsByYear W20681270302022 @default.
• W2068127030 crossrefType "journal-article" @default.
• W2068127030 hasAuthorship W2068127030A5007451076 @default.
• W2068127030 hasAuthorship W2068127030A5015105864 @default.
• W2068127030 hasAuthorship W2068127030A5017782497 @default.
• W2068127030 hasAuthorship W2068127030A5018746510 @default.
• W2068127030 hasAuthorship W2068127030A5052479060 @default.
• W2068127030 hasAuthorship W2068127030A5056709060 @default.
• W2068127030 hasAuthorship W2068127030A5063922177 @default.
• W2068127030 hasAuthorship W2068127030A5073113713 @default.
• W2068127030 hasAuthorship W2068127030A5074118804 @default.
• W2068127030 hasAuthorship W2068127030A5077685439 @default.
• W2068127030 hasAuthorship W2068127030A5080828723 @default.
• W2068127030 hasConcept C118552586 @default.
• W2068127030 hasConcept C121332964 @default.
• W2068127030 hasConcept C126322002 @default.
• W2068127030 hasConcept C142424586 @default.
• W2068127030 hasConcept C187212893 @default.
• W2068127030 hasConcept C188816634 @default.
• W2068127030 hasConcept C197934379 @default.
• W2068127030 hasConcept C2777332695 @default.
• W2068127030 hasConcept C2777496795 @default.
• W2068127030 hasConcept C2777803345 @default.
• W2068127030 hasConcept C2778186239 @default.
• W2068127030 hasConcept C2779384505 @default.
• W2068127030 hasConcept C2779979230 @default.
• W2068127030 hasConcept C2780820931 @default.
• W2068127030 hasConcept C2780874087 @default.
• W2068127030 hasConcept C3019985608 @default.
• W2068127030 hasConcept C42219234 @default.
• W2068127030 hasConcept C558461103 @default.
• W2068127030 hasConcept C71924100 @default.
• W2068127030 hasConcept C87355193 @default.
• W2068127030 hasConceptScore W2068127030C118552586 @default.
• W2068127030 hasConceptScore W2068127030C121332964 @default.
• W2068127030 hasConceptScore W2068127030C126322002 @default.
• W2068127030 hasConceptScore W2068127030C142424586 @default.
• W2068127030 hasConceptScore W2068127030C187212893 @default.
• W2068127030 hasConceptScore W2068127030C188816634 @default.
• W2068127030 hasConceptScore W2068127030C197934379 @default.
• W2068127030 hasConceptScore W2068127030C2777332695 @default.
• W2068127030 hasConceptScore W2068127030C2777496795 @default.
• W2068127030 hasConceptScore W2068127030C2777803345 @default.
• W2068127030 hasConceptScore W2068127030C2778186239 @default.
• W2068127030 hasConceptScore W2068127030C2779384505 @default.
• W2068127030 hasConceptScore W2068127030C2779979230 @default.
• W2068127030 hasConceptScore W2068127030C2780820931 @default.
• W2068127030 hasConceptScore W2068127030C2780874087 @default.
• W2068127030 hasConceptScore W2068127030C3019985608 @default.
• W2068127030 hasConceptScore W2068127030C42219234 @default.
• W2068127030 hasConceptScore W2068127030C558461103 @default.
• W2068127030 hasConceptScore W2068127030C71924100 @default.
• W2068127030 hasConceptScore W2068127030C87355193 @default.
• W2068127030 hasIssue "1" @default.
• W2068127030 hasLocation W20681270301 @default.
• W2068127030 hasLocation W20681270302 @default.
• W2068127030 hasOpenAccess W2068127030 @default.
• W2068127030 hasPrimaryLocation W20681270301 @default.
• W2068127030 hasRelatedWork W1996122044 @default.
• W2068127030 hasRelatedWork W2012649957 @default.

• next